Literature DB >> 16749331

Fistula First: the National Vascular Access Improvement Initiative.

Jay A Gold1, Kristine Hoffman.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16749331

Source DB:  PubMed          Journal:  WMJ        ISSN： 1098-1861


× No keyword cloud information.
  6 in total

1.  In vivo nanoparticle assessment of pathological endothelium predicts the development of inflow stenosis in murine arteriovenous fistula.

Authors:  Jie Cui; Chase W Kessinger; Jason R McCarthy; David E Sosnovik; Peter Libby; Ravi I Thadhani; Farouc A Jaffer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-11-13       Impact factor: 8.311

2.  Decreased cumulative access survival in arteriovenous fistulas requiring interventions to promote maturation.

Authors:  Timmy Lee; Ahsan Ullah; Michael Allon; Paul Succop; Mahmoud El-Khatib; Rino Munda; Prabir Roy-Chaudhury
Journal:  Clin J Am Soc Nephrol       Date:  2010-11-18       Impact factor: 8.237

Review 3.  Preoperative vascular access evaluation for haemodialysis patients.

Authors:  Sarah D Kosa; Ahmed A Al-Jaishi; Louise Moist; Charmaine E Lok
Journal:  Cochrane Database Syst Rev       Date:  2015-09-30

4.  Ultrasound evaluation of percutaneously created arteriovenous fistulae between radial artery and perforating vein at the elbow.

Authors:  Gilbert Franco; Alexandros Mallios; Pierre Bourquelot; William Jennings; Benoit Boura
Journal:  J Vasc Access       Date:  2020-01-10       Impact factor: 2.283

5.  Observational study of the efficacy of supraclavicular brachial plexus block for arteriovenous fistula creation.

Authors:  Selvakumar Palaniappan; Venkatesh Subbiah; V Raja Gopalan; Poornima Vijaya Kumar; R John Santa Vinothan
Journal:  Indian J Anaesth       Date:  2018-08

6.  Added value of clinical prediction rules for bacteremia in hemodialysis patients: An external validation study.

Authors:  Sho Sasaki; Yoshihiko Raita; Minoru Murakami; Shungo Yamamoto; Kentaro Tochitani; Takeshi Hasegawa; Kiichiro Fujisaki; Shunichi Fukuhara
Journal:  PLoS One       Date:  2021-02-22       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.